MIL62

· Beijing Mabworks Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for MIL62, covering 2024-02-07 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus [Phase 3]